169 search results for: burden of disease

The Multifactorial <b>Burden</b>s <b>of</b> Bullous Pemphigoid
Dermatology
The Multifactorial Burdens of Bullous Pemphigoid
expert video

Professor Dédée Murrell explains the challenges in managing patients with bullous pemphigoid at EADV 2025.

View more
Uncovering the Impact <b>of</b> Moderate COPD Exacerbations
Pulmonology
Uncovering the Impact of Moderate COPD Exacerbations
interactivity

The infographic provides information about the clinical characteristics used to classify moderate COPD exacerbations and the impact of these events on lung function, future risk, and mortality.

View more
Understanding the Full Scope <b>of</b> PN: Lesions, Dyspigmentation, and Patient <b>Burden</b>
Dermatology
Understanding the Full Scope of PN: Lesions, Dyspigmentation, and Patient Burden
expert video

Professor Matthias Augustin details the various clinical manifestations of prurigo nodularis, illustrating how different lesion types can present concurrently in patients.

View more
AANP 2025 | Atopic <b>Disease</b>s & a Case-Based Panel <b>of</b> Nurse Practitioners
Type 2 Inflammation
AANP 2025 | Atopic Diseases & a Case-Based Panel of Nurse Practitioners
videoanimation

Experts from different specialties use a case-based discussion to understand type 2 inflammatory diseases from a nurse practitioner perspective.

View more
Managing Type 2 Inflammatory <b>Disease</b>s: Multidisciplinary Frame <b>of</b> Mind
Type 2 Inflammation
Managing Type 2 Inflammatory Diseases: Multidisciplinary Frame of Mind
expert video

Drs. Bob Geng and Lawrence Eichenfield highlight a multidisciplinary team approach to patient-centered care in diseases with type 2 inflammation

View more
Understanding IL-33: A Key Factor in COPD Pathogenesis
Pulmonology
Understanding IL-33: A Key Factor in COPD Pathogenesis
interactivity

Explore the role of interleukin (IL)-33 in chronic obstructive pulmonary disease (COPD) pathophysiology and its potential as a therapeutic target.

View more
EAACI 2025 | At The Intersection <b>of</b> the Type 2 Airways: Navigating the Challenges <b>of</b> CRSwNP & Co-existing Asthma
Type 2 Inflammation
EAACI 2025 | At The Intersection of the Type 2 Airways: Navigating the Challenges of CRSwNP & Co-existing Asthma
expert video

Professors Brian Lipworth, Zuzana Diamant, and Philippe Gevaert delve into the complexities of managing patients with both severe and/or uncontrolled CRSwNP and co-existing asthma through an evaluation of the diagnostic challenges, personalized treatment strategies, and the latest advancements in understanding the interconnected pathophysiology of these type 2 airway diseases.

View more
ERS-ISIAN 2025 | <b>Disease</b> Control in CRSwNP
Rhinology
ERS-ISIAN 2025 | Disease Control in CRSwNP
expert video

Unpack the keys to successful disease control in CRSwNP alongside expert Prof. Vibeke Backer. Learn how to navigate treatment pathways for improved patient quality of life.

View more
ADVENT at ERS 2024
On Demand
ERS 2024 | A Breath of Fresh Air: A Greater Understanding of COPD With Type 2 Inflammation

Join experts Henrik Watz, Mona Bafadhel, and Alberto Papi for an educational symposium on the link between underlying drivers of COPD with type 2 inflammation and cumulative patient burden, exploring the role of type 2 cytokines, and current and emerging therapies.

Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional <b>Disease</b> <b>Burden</b>
Dermatology
Digging Deeper: Reducing Non-Atopic Comorbidities and Multidimensional Disease Burden
expert video

In this clip from the April WCPD 2025 symposium, Dr Paula Luna discusses how moderate-to-severe AD may hinder growth in pediatric patients.

View more
Atopic Dermatitis and the Risk <b>of</b> Developing Other Atopic <b>Disease</b>s
Dermatology
Atopic Dermatitis and the Risk of Developing Other Atopic Diseases
expert video

In this soundbite video from the April 2025 ADVENT Forum in Lisbon, Portugal, Dr Amy Paller discusses the significant risk of developing other atopic diseases among infants with early-onset atopic dermatitis.

View more
ERS-ISIAN 2025 | Type 2 Inflammation and <b>Disease</b> Control in CRSwNP: Current Perspectives and Future Directions
Rhinology
ERS-ISIAN 2025 | Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions
expert video

The ERS-ISIAN 2025 symposium, featuring Prof. Vibeke Backer and Prof. Sietze Reitsma, titled "Type 2 Inflammation and Disease Control in CRSwNP: Current Perspectives and Future Directions," will delve into the complexities of the role of type 2 inflammation in CRSwNP.

View more